| First Author | Wilkinson H | Year | 2021 |
| Journal | iScience | Volume | 24 |
| Issue | 1 | Pages | 101981 |
| PubMed ID | 33458623 | Mgi Jnum | J:322010 |
| Mgi Id | MGI:6718191 | Doi | 10.1016/j.isci.2020.101981 |
| Citation | Wilkinson H, et al. (2021) PAR-1 signaling on macrophages is required for effective in vivo delayed-type hypersensitivity responses. iScience 24(1):101981 |
| abstractText | Delayed-type hypersensitivity (DTH) responses underpin chronic inflammation. Using a model of oxazolone-induced dermatitis and a combination of transgenic mice, adoptive cell transfer, and selective agonists/antagonists against protease activated receptors, we show that that PAR-1 signaling on macrophages by thrombin is required for effective granuloma formation. Using BM-derived macrophages (BMMs) in vitro, we show that thrombin signaling induced (a) downregulation of cell membrane reverse cholesterol transporter ABCA1 and (b) increased expression of IFNgamma receptor and enhanced co-localization within increased areas of cholesterol-rich membrane microdomains. These two key phenotypic changes combined to make thrombin-primed BMMs sensitive to M1 polarization by 1000-fold less IFNgamma, compared to resting BMMs. We confirm that changes in ABCA1 expression were directly responsible for the exquisite sensitivity to IFNgamma in vitro and for the impact on granuloma formation in vivo. These data indicate that PAR-1 signaling plays a hitherto unrecognized and critical role in DTH responses. |
